ATP-competitive inhibitor of MAPK7



Protein target names: MAPK7

Mechanism of action: ATP-competitive inhibitor

Recommended in-cell concentration:
500 nM

In Vitro Validations

Uniprot ID: Q13164
Target Class: Kinase
Target SubClass: CMGC
Potency: Kd
Potency Value: 8 nM
Potency Assay: KiNativ (
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Mitogen-activated protein kinase 7, PRKM7, ERK5, B ...

DOI Reference: 10.1073/pnas.1609019113

In Cell Validations

In Vivo Data

Reagent authentication certificate: PDF image

I have extra information to add

SERP ratings and comments

SERP Ratings

In Cell Rating

SERP Comments:

This probe might be suitable for in vivo studies via non-standard dosing technologies (minipump or IP injection, twice daily with CYP inhibitor co-dosing) but not enough ADME data are provided to know which technology could work.

(last updated: 11 Dec 2016 )

SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

A thorough exploration of the cellular effects of the compound is presented, but the DMPK data are not sufficiently good to allow in vivo evaluation via standard oral or IV dosing.

(last updated: 22 Mar 2017 )

SERP Ratings

In Cell Rating

SERP Comments:

The probe is a potent and selective ERK5 inhibitor. The data look convincing, and selectivity against other kinases is particularly strong (limited other selectivity data disclosed aside from key bromodomain targets). Importantly, data are presented for target engagement within the cell and cellular and isolated biochemical potencies are similar. Recommended for use in vitro and/or in cells. No data were ncluded to support use of this probe in model organisms.

(last updated: 30 Mar 2017 )